Rare diseases
Investigational molecules
Locations
Back to Croatia7 clinical trials in Ivanic-Grad, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
CroatiaStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
CroatiaStudy on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults
CroatiaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
CroatiaStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
CroatiaStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
CroatiaStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atopic dermatitis are evaluating new therapeutic approaches for both adolescents and adults with moderate to severe conditions. The research aims to assess novel treatment combinations and their effectiveness in managing eczema symptoms.
Research includes evaluation of topical corticosteroid combinations and long-term treatment outcomes.
Studies are underway examining treatments for hidradenitis suppurativa, particularly focusing on patients who haven't responded well to conventional therapies. This research explores alternative treatment options for moderate to severe cases.
The research specifically targets patients who have shown resistance to traditional treatments.
Cutting-edge research investigating rezpegaldesleukin and other novel biologics for treating moderate-to-severe skin conditions. These trials are specifically designed for biologic-naive patients seeking new treatment options.
Focus includes measuring treatment effectiveness through standardized assessment tools.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
